Spatial Omics Market - Global Industry Analysis

Spatial Omics Market - By Technique (Spatial Transcriptomic, Spatial Proteomics, and Spatial Genomics), By Product (Instrument, Software, and Consumables), By End-User (Academic Institutes, CROs, and Research Institutes), And By Region- Global Industry Perspective, Comprehensive Analysis, and Forecast, 2021 – 2028

Published Date: 19-Jul-2021 Category: Biotechnology Report Format : PDF Pages: 140 Report Code: ZMR-6492 Status : Published

The global Spatial Omics market accrued earnings worth approximately 176 (USD Million) in 2020 and is predicted to gain revenue of about 625(USD Million) by 2028, is set to record a CAGR of nearly 17.5% over the period from 2021 to 2028.

Description

Spatial Omics Market Size And Industry Analysis

The global Spatial Omics market accrued earnings worth approximately 176 (USD Million) in 2020 and is predicted to gain revenue of about 625(USD Million) by 2028, is set to record a CAGR of nearly 17.5% over the period from 2021 to 2028. The report offers assessment and analysis of the Spatial Omics market on a global and regional level. The study offers a comprehensive assessment of the market competition, constraints, revenue estimates, opportunities, evolving trends, and industry-validated data. The report provides historical data from 2018 to 2020 along with a forecast from 2021 to 2028 based on revenue (USD Million).

Report Scope :

Report Attribute Details
Base Year 2020
Historic Years 2016 - 2020
Forecast Years 2021 - 2028
Segments Covered By Product Type, By Application, and By End Use
Forecast Units Value (USD Billion), and Volume (Units)
Quantitative Units Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered 10 companies with scope for including additional 15 companies upon request
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope Avail customized purchase options to meet your exact research needs.

Spatial Omics Market: Overview

Complicated intercellular interactions and bio-molecular cues from extracellular matrix (ECM) severely impact cell functions. However, conventional proteomic & transcriptomic approaches have offered deeper insights into disease proliferation through identification of discrete cell population along with other pathological issues. Nevertheless, these methods are not able to accurately assess as to how a cellular state can relate interactions with surrounding cells. Moreover, spatial omics methods provide high resolution mapping of expression profiles of cell tissues similar to that provided by mass spectroscopy. Ability to retain spatial content of various cells in samples along with their cellular geometry and surrounding ECM is likely to offer spatial omics with an opportunity of exploring unexplored signal modalities, thereby brining a paradigm shift in ECM research activities & our understanding of fibrotic ailments.  

Spatial Omics Market: Growth Drivers

Surge in acceptance of spatial genomics by start-ups and small firms along with its massive use in biomarker identification will drive market trends. In addition to this, rise in application of spatial genomics in drug development and medicine discovery will create lucrative avenues for spatial omics industry in foreseeable future. Rise in allocation of funds in biopharmaceutical sector will enlarge application scope of spatial omics in upcoming years. Nevertheless, low awareness about spatial omics methods in developing economies as well as high device costs will restraint growth of spatial omics industry over forecast timespan.

Furthermore, rapid spread of COVID pandemics has further boosted growth of spatial omics market over assessment period. Breakthroughs in tissue sequencing, gene sequencing, and single cell sequencing have led to evolution of spatial genomic sequencing methods, thereby driving spatial omics market expansion. In addition to this, growth of new techniques for spatial omics is set to produce lucrative avenues for research & diagnostics, thereby enhancing size of spatial omics industry.    

Global Spatial Omics Market

Regional Landscape

North American Market To Acquire Numero Uno Position By 2028

The regional market expansion during forecast timeline can be attributed to rise in cancer cases along with escalating necessity of personalized drugs. Apart from this, presence of robust healthcare infrastructure & amenities and access to new diagnostic methods will define growth of business in sub-continent over assessment period. Rise in rate of mortality owing to surge in cancer, autoimmune disorders, inflammatory ailments, and metabolic diseases will generate need for new medical treatment modes, thereby boosting regional market trends.

Competitive Landscape

Key participants profiled in study and leveraging market growth include PerkinElmer, Inc., Dovetail Genomics, IonPath, Inc., Nanostring Technologies, Inc., Seven Bridges Genomics, Danaher Corporation, Bio-Techne, Akoya Biosciences, Inc., Diagenode Diagnostics, S2 Genomics, Inc., Biognosys AG, Vizgen Corporation, Bruker Corporation, Brooks Automation, Inc., BioSpyder Technologies, and Rebus Biosystems.

The global Spatial Omics Market is segmented as follows:

By End-User

  • Academic Institutes
  • CROs
  • Research Institutes

By Technique

By Product

  • Instrument
  • Software
  • Consumables

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

  • Chapter 1. Preface
    • 1.1. Report Description and Scope
    • 1.2. Research Scope
    • 1.3. Research Methodology
      • 1.3.1. Market Research Type
      • 1.3.2. Market Research Methodology
  • Chapter 2. Executive Summary
    • 2.1. Spatial Omics Market, 2018–2028(USD Million)
    • 2.2. Spatial Omics Market: Snapshot
  • Chapter 3. Global Spatial Omics Market– End-User Analysis
    • 3.1. Spatial Omics Market: Market Dynamics
    • 3.2. Market Drivers
      • 3.2.1. Increase in acceptance of spatial genomics by start-ups and small organizations along with its huge utilization in biomarker identification will drive market trends.
      • 3.2.2. Rise in application of spatial genomics in drug development and discovery will boost spatial omics industry in near future.
    • 3.3. Porter’s Five Forces Analysis
    • 3.4. Market Attractiveness Analysis
      • 3.4.1. Market attractiveness analysis By End-User
      • 3.4.2. Market attractiveness analysis By Technique
      • 3.4.3. Market attractiveness analysis By Product
  • Chapter 4. Global Spatial Omics Market– Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global Spatial Omics Market: company market share, 2019
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New Biotechnulogy launches
      • 4.2.3. Agreements, partnerships, cullaborations, and joint ventures
      • 4.2.4. Research and development and Regional expansion
    • 4.3. Price trend analysis
  • Chapter 5. Global Spatial Omics Market– End-User Analysis
    • 5.1. Global Spatial Omics Market overview: By End-User
      • 5.1.1. Global Spatial Omics Market share, By End-User , 2020 and 2028
    • 5.2. Academic Institutes
      • 5.2.1. Global Spatial Omics Market by Academic Institutes, 2018–2028(USD Million)
    • 5.3. CROs
      • 5.3.1. Global Spatial Omics Market by CROs, 2018–2028(USD Million)
    • 5.4. Research Institutes
      • 5.4.1. Global Spatial Omics Market by Research Institutes, 2018–2028(USD Million)
  • Chapter 6. Global Spatial Omics Market– Technique Analysis
    • 6.1. Global Spatial Omics Market overview: By Technique
      • 6.1.1. Global Spatial Omics Market share, By Technique, 2020 and 2028
    • 6.2. Spatial Transcriptomic
      • 6.2.1. Global Spatial Omics Market by Spatial Transcriptomic, 2018–2028(USD Million)
    • 6.3. Spatial Genomics
      • 6.3.1. Global Spatial Omics Market by Spatial Genomics, 2018–2028(USD Million)
    • 6.4. Spatial Proteomics
      • 6.4.1. Global Spatial Omics Market by Spatial Proteomics, 2018–2028(USD Million)
  • Chapter 7. Global Spatial Omics Market– Product Analysis
    • 7.1. Global Spatial Omics Market overview: By Product
      • 7.1.1. Global Spatial Omics Market share, By Product, 2020 and 2028
    • 7.2. Instrument
      • 7.2.1. Global Spatial Omics Market by Instrument, 2018–2028(USD Million)
    • 7.3. Software
      • 7.3.1. Global Spatial Omics Market by Software, 2018–2028(USD Million)
    • 7.4. Consumables
      • 7.4.1. Global Spatial Omics Market by Consumables, 2018–2028(USD Million)
  • Chapter 8. Company Profiles
    • 8.1. PerkinElmer, Inc.
      • 8.1.1. Overview
      • 8.1.2. Financials
      • 8.1.3. Biotechnulogy Portfolio
      • 8.1.4. Business Strategy
      • 8.1.5. Recent Developments
    • 8.2. Dovetail Genomics
      • 8.2.1. Overview
      • 8.2.2. Financials
      • 8.2.3. Biotechnulogy Portfolio
      • 8.2.4. Business Strategy
      • 8.2.5. Recent Developments
    • 8.3. IonPath, Inc.
      • 8.3.1. Overview
      • 8.3.2. Financials
      • 8.3.3. Biotechnulogy Portfolio
      • 8.3.4. Business Strategy
      • 8.3.5. Recent Development
    • 8.4. Nanostring Technulogies, Inc.
      • 8.4.1. Overview
      • 8.4.2. Financials
      • 8.4.3. Biotechnulogy Portfolio
      • 8.4.4. Business Strategy
      • 8.4.5. Recent Development
    • 8.5. Seven Bridges Genomics
      • 8.5.1. Overview
      • 8.5.2. Financials
      • 8.5.3. Biotechnulogy Portfolio
      • 8.5.4. Business Strategy
      • 8.5.5. Recent Development
    • 8.6. Danaher Corporation
      • 8.6.1. Overview
      • 8.6.2. Financials
      • 8.6.3. Biotechnulogy Portfolio
      • 8.6.4. Business Strategy
      • 8.6.5. Recent Development
    • 8.7. Bio-Techne
      • 8.7.1. Overview
      • 8.7.2. Financials
      • 8.7.3. Biotechnulogy Portfolio
      • 8.7.4. Business Strategy
      • 8.7.5. Recent Development
    • 8.8. Akoya Biosciences, Inc.
      • 8.8.1. Overview
      • 8.8.2. Financials
      • 8.8.3. Biotechnulogy Portfolio
      • 8.8.4. Business Strategy
      • 8.8.5. Recent Development
    • 8.9. Diagenode Diagnostics
      • 8.9.1. Overview
      • 8.9.2. Financials
      • 8.9.3. Biotechnulogy Portfolio
      • 8.9.4. Business Strategy
      • 8.9.5. Recent Development
    • 8.10. S2 Genomics, Inc.
      • 8.10.1. Overview
      • 8.10.2. Financials
      • 8.10.3. Biotechnulogy Portfolio
      • 8.10.4. Business Strategy
      • 8.10.5. Recent Development
    • 8.11. Biognosys AG
      • 8.11.1. Overview
      • 8.11.2. Financials
      • 8.11.3. Biotechnulogy Portfolio
      • 8.11.4. Business Strategy
      • 8.11.5. Recent Development
    • 8.12. Vizgen Corporation
      • 8.12.1. Overview
      • 8.12.2. Financials
      • 8.12.3. Biotechnulogy Portfolio
      • 8.12.4. Business Strategy
      • 8.12.5. Recent Development
    • 8.13. Bruker Corporation
      • 8.13.1. Overview
      • 8.13.2. Financials
      • 8.13.3. Biotechnulogy Portfolio
      • 8.13.4. Business Strategy
      • 8.13.5. Recent Development
    • 8.14. Brooks Automation, Inc.
      • 8.14.1. Overview
      • 8.14.2. Financials
      • 8.14.3. Biotechnulogy Portfolio
      • 8.14.4. Business Strategy
      • 8.14.5. Recent Development
    • 8.15. Rebus Biosystems
      • 8.15.1. Overview
      • 8.15.2. Financials
      • 8.15.3. Biotechnulogy Portfolio
      • 8.15.4. Business Strategy
      • 8.15.5. Recent Development
    • 8.16. BioSpyder Technulogies
      • 8.16.1. Overview
      • 8.16.2. Financials
      • 8.16.3. Biotechnulogy Portfolio
      • 8.16.4. Business Strategy
      • 8.16.5. Recent Development

Table Of Figures

List of Figures

1. Market research Type
2. Market research methodology
3. Global Spatial Omics Market, 2018–2028(USD Million)
4. Porter’s Five Forces Analysis
5. Global Spatial Omics Marketattractiveness, By End-User
6. Global Spatial Omics Marketattractiveness, By Technique
7. Global Spatial Omics Marketattractiveness, By Product
8. Global Spatial Omics Marketshare by End-User ,2020 and 2028 (USD Million)
9. Global Spatial Omics Marketby Academic Institutes, 2018–2028(USD Million)
10. Global Spatial Omics Marketby CROs, 2018–2028(USD Million)
11. Global Spatial Omics Marketby Research Institutes, 2018–2028(USD Million)
12. Global Spatial Omics Marketshare by Technique ,2020 and 2028 (USD Million)
13. Global Spatial Omics Marketby Spatial Transcriptomic, 2018–2028(USD Million)
14. Global Spatial Omics Marketby Spatial Genomics, 2018–2028(USD Million)
15. Global Spatial Omics Marketby Spatial Proteomics, 2018–2028(USD Million)
16. Global Spatial Omics Marketshare by Product ,2020 and 2028 (USD Million)
17. Global Spatial Omics Marketby Instrument, 2018–2028(USD Million)
18. Global Spatial Omics Marketby Software, 2018–2028(USD Million)
19. Global Spatial Omics Marketby Consumables, 2018–2028(USD Million)
20. Global Spatial Omics Marketshare, by Region, 2020 and 2028
21. North America Spatial Omics Market, 2018–2028(USD Million)
22. Europe Spatial Omics Market, 2018–2028(USD Million)
23. Asia Pacific Spatial Omics Market, 2018–2028(USD Million)
24. Latin America Spatial Omics Market, 2018–2028(USD Million)
25. The Middle East and Africa Spatial Omics Market, 2018–2028(USD Million)
 


Table Of Tables

List of Tables

1. Global Spatial Omics Market: snapshot
2. Drivers of the Spatial Omics Market: impact analysis
3. North America Spatial Omics Market revenue, By End-User  ,2018–2028(USD Million)
4. North America Spatial Omics Market revenue, By Technique  ,2018–2028(USD Million)
5. North America Spatial Omics Market revenue, By Product  ,2018–2028(USD Million)
6. The U.S. Spatial Omics Market revenue, By End-User  ,2018–2028(USD Million)
7. The U.S. Spatial Omics Market revenue, By Technique  ,2018–2028(USD Million)
8. The U.S. Spatial Omics Market revenue, By Product  ,2018–2028(USD Million)
9. Rest of North America Spatial Omics Market revenue, By End-User  ,2018–2028(USD Million)
10. Rest of North America Spatial Omics Market revenue, By Technique  ,2018–2028(USD Million)
11. Rest of North America Spatial Omics Market revenue, By Product  ,2018–2028(USD Million)
12. Europe Spatial Omics Market revenue, By End-User  ,2018–2028(USD Million)
13. Europe Spatial Omics Market revenue, By Technique  ,2018–2028(USD Million)
14. Europe Spatial Omics Market revenue, By Product  ,2018–2028(USD Million)
15. UK Spatial Omics Market revenue, By End-User  ,2018–2028(USD Million)
16. UK Spatial Omics Market revenue, By Technique  ,2018–2028(USD Million)
17. UK Spatial Omics Market revenue, By Product  ,2018–2028(USD Million)
18. France Spatial Omics Market revenue, By End-User  ,2018–2028(USD Million)
19. France Spatial Omics Market revenue, By Technique  ,2018–2028(USD Million)
20. France Spatial Omics Market revenue, By Product  ,2018–2028(USD Million)
21. Germany Spatial Omics Market revenue, By End-User  ,2018–2028(USD Million)
22. Germany Spatial Omics Market revenue, By Technique  ,2018–2028(USD Million)
23. Germany Spatial Omics Market revenue, By Product  ,2018–2028(USD Million)
24. Rest of Europe Spatial Omics Market revenue, By End-User  ,2018–2028(USD Million)
25. Rest of Europe Spatial Omics Market revenue, By Technique  ,2018–2028(USD Million)
26. Rest of Europe Spatial Omics Market revenue, By Product  ,2018–2028(USD Million)
27. Asia Pacific Spatial Omics Market revenue, By End-User  ,2018–2028(USD Million)
28. Asia Pacific Spatial Omics Market revenue, By Technique  ,2018–2028(USD Million)
29. Asia Pacific Spatial Omics Market revenue, By Product  ,2018–2028(USD Million)
30. China Spatial Omics Market revenue, By End-User  ,2018–2028(USD Million)
31. China Spatial Omics Market revenue, By Technique  ,2018–2028(USD Million)
32. China Spatial Omics Market revenue, By Product  ,2018–2028(USD Million)
33. Japan Spatial Omics Market revenue, By End-User  ,2018–2028(USD Million)
34. Japan Spatial Omics Market revenue, By Technique  ,2018–2028(USD Million)
35. Japan Spatial Omics Market revenue, By Product  ,2018–2028(USD Million)
36. India Spatial Omics Market revenue, By End-User  ,2018–2028(USD Million)
37. India Spatial Omics Market revenue, By Technique  ,2018–2028(USD Million)
38. India Spatial Omics Market revenue, By Product  ,2018–2028(USD Million)
39. Rest of Asia Pacific Spatial Omics Market revenue, By End-User  ,2018–2028(USD Million)
40. Rest of Asia Pacific Spatial Omics Market revenue, By Technique  ,2018–2028(USD Million)
41. Rest of Asia Pacific Spatial Omics Market revenue, By Product  ,2018–2028(USD Million)
42. Latin America Spatial Omics Market revenue, By End-User  ,2018–2028(USD Million)
43. Latin America Spatial Omics Market revenue, By Technique  ,2018–2028(USD Million)
44. Latin America Spatial Omics Market revenue, By Product  ,2018–2028(USD Million)
45. Brazil Spatial Omics Market revenue, By End-User  ,2018–2028(USD Million)
46. Brazil Spatial Omics Market revenue, By Technique  ,2018–2028(USD Million)
47. Brazil Spatial Omics Market revenue, By Product  ,2018–2028(USD Million)
48. Rest of Latin America Spatial Omics Market revenue, By End-User  ,2018–2028(USD Million)
49. Rest of Latin America Spatial Omics Market revenue, By Technique  ,2018–2028(USD Million)
50. Rest of Latin  America Spatial Omics Market revenue, By Product  ,2018–2028(USD Million)
51. The Middle East and Africa Spatial Omics Market revenue, By End-User  ,2018–2028(USD Million)
52. The Middle East and Africa Spatial Omics Market revenue, By Technique  ,2018–2028(USD Million)
53. The Middle East and Africa Spatial Omics Market revenue, By Product  ,2018–2028(USD Million)
54. Saudi Arabia Spatial Omics Market revenue, By End-User  ,2018–2028(USD Million)
55. Saudi Arabia Spatial Omics Market revenue, By Technique  ,2018–2028(USD Million)
56. Saudi Arabia Spatial Omics Market revenue, By Product  ,2018–2028(USD Million)
57. South Africa Spatial Omics Market revenue, By End-User  ,2018–2028(USD Million)
58. South Africa Spatial Omics Market revenue, By Technique  ,2018–2028(USD Million)
59. South Africa Spatial Omics Market revenue, By Product  ,2018–2028(USD Million)
60. Rest of the Middle East & Africa Spatial Omics Market revenue, By End-User  ,2018–2028(USD Million)
61. Rest of the Middle East & Africa Spatial Omics Market revenue, By Technique  ,2018–2028(USD Million)
62. Rest of the Middle East & Africa Spatial Omics Market revenue, By Product  ,2018–2028(USD Million)

 
  
 

Methodology

Choose License Type

Request the coronavirus impact analysis across industries and markets

FrequentlyAsked Questions

Surge in acceptance of spatial genomics by start-ups and small firms along with its massive use in biomarker identification will drive market trends. In addition to this, rise in application of spatial genomics in drug development and medicine discovery will create lucrative avenues for spatial omics industry in foreseeable future. Rise in allocation of funds in biopharmaceutical sector will enlarge application scope of spatial omics in upcoming years.

Furthermore, rapid spread of COVID pandemics has further boosted growth of spatial omics market over assessment period. Breakthroughs in tissue sequencing, gene sequencing, and single cell sequencing have led to evolution of spatial genomic sequencing methods, thereby driving spatial omics market expansion.

According to Zion market research report, the global Spatial Omics market accrued earnings worth approximately 176 (USD Million) in 2020 and is predicted to gain revenue of about 625(USD Million) by 2028, is set to record a CAGR of nearly 17.5% over the period from 2021 to 2028.

North America will contribute lucratively towards the global market size over the estimated timeline. The regional market surge is due to rise in cancer cases along with escalating necessity of personalized drugs. Apart from this, presence of robust healthcare infrastructure & amenities and access to new diagnostic methods will define growth of business in sub-continent over assessment period. Rise in rate of mortality owing to surge in cancer, autoimmune disorders, inflammatory ailments, and metabolic diseases will generate need for new medical treatment modes, thereby boosting regional market trends.  

The key market participants include PerkinElmer, Inc., Dovetail Genomics, IonPath, Inc., Nanostring Technologies, Inc., Seven Bridges Genomics, Danaher Corporation, Bio-Techne, Akoya Biosciences, Inc., Diagenode Diagnostics, S2 Genomics, Inc., Biognosys AG, Vizgen Corporation, Bruker Corporation, Brooks Automation, Inc., BioSpyder Technologies, and Rebus Biosystems.

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • paypal
  • amazon
  • visa
  • master card

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed